Dr Mike Leach has developed compounds, known as UoG-alpha and UoG-beta, that can inhibit the multiple cytokine proteins that can cause death by respiratory collapse, following Covid 19 infection. These compounds can be used within a drug therapy to prevent our immune system from disabling the body’s lung function during a cytokine storm; one of the contributing factors in Covid-19 deaths. This treatment could potentially also help protect cancer and organ transplant patients.
My Clearing success story at Brighton My account as a student who went through the Clearing process and successfully got onto the course of my dreams! My Personal Clearing Experience …
Six key questions students in Clearing should ask this year Coventry University Provost Ian Dunn The countdown to the biggest day of thousands of students’ lives so far has begun.…
2024 graduate Alix shares how Clearing allowed her to join RGU, her university of choice, after she didn’t get the grades she needed to have her first offer accepted. She tells…
